First-in-human implantation of a novel self-expanding supra-annular transcatheter heart valve for transcatheter aortic valve implantation inside a small degenerated aortic surgical bioprosthesis

Ulrich Schäfer; Daniel Kalbacher; Lisa Voigtländer; Lenard Conradi

doi:10.1002/ccd.27466

First-in-human implantation of a novel self-expanding supra-annular transcatheter heart valve for transcatheter aortic valve implantation inside a small degenerated aortic surgical bioprosthesis

Catheter Cardiovasc Interv. 2018 Dec 1;92(7):1453-1457. doi: 10.1002/ccd.27466. Epub 2018 Jan 23.

Authors

Ulrich Schäfer¹, Daniel Kalbacher¹, Lisa Voigtländer¹, Lenard Conradi²

Affiliations

¹ Department of Cardiology, University Heart Center, Hamburg, Germany.
² Department of Cardiac Surgery, University Heart Center, Hamburg, Germany.

PMID: 29359506
DOI: 10.1002/ccd.27466

Abstract

With next-generation valves such as the ALLEGRA valve from NewValve Technologies (NVT), Hechingen Germany, there is a very likely treatment expansion for patients with aortic valve disease. Besides treatment of native valvular aortic stenosis with the ALLEGRA valve, the special implant mechanism seems to be an appealing concept for patients with degenerated surgical bioprostheses. We report the first case of a transfemoral implantation in small degenerated surgical bioprosthesis of a 76-year-old woman.

Keywords: intervention; new devices; structural heart disease; transcatheter valve implantation.

Publication types

Case Reports
Video-Audio Media

MeSH terms

Aged
Aortic Valve / diagnostic imaging
Aortic Valve / physiopathology
Aortic Valve / surgery*
Bioprosthesis*
Female
Heart Valve Prosthesis Implantation / adverse effects
Heart Valve Prosthesis Implantation / instrumentation*
Heart Valve Prosthesis*
Humans
Prosthesis Design
Prosthesis Failure*
Recovery of Function
Transcatheter Aortic Valve Replacement / instrumentation*
Treatment Outcome